itherx Pharmaceuticals Receives $2,800,000 New Funding

  • Feed Type
  • Date
    5/17/2010
  • Company Name
    itherx Pharmaceuticals
  • Mailing Address
    10790 Roselle St. San Diego, CA 92121
  • Company Description
    iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world’s population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer.
  • Website
    http://www.itherx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed